Nexus Finance
TORNTPHARM.NS TORRENT PHARMACEUTICALS L | INE685A01028

Company Profile

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Latest News

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Website https://www.torrentpharma.com
Audit Risk 2
Board Risk 3
Overall Risk 3
Market Cap 1.92T
Trailing P/E 78.71
Forward P/E 53.61
Dividend Rate 38
Dividend Yield 0.77%
Trailing Annual Div. Rate 38
Trailing Annual Div. Yield 0.77%
Trailing EPS 64
Forward EPS 93.97
Book Value 247.85
Price-to-Book 20.32
Enterprise-to-Revenue 13.58
Enterprise-to-EBITDA 42.21
Ex-Dividend Date 05/29/2026
Earnings Date 07/30/2026
Earnings Call Date 07/30/2026
Earnings Average 14.93
Earnings Low 11.7
Earnings High 17.1
Revenue Average 47.17B
Revenue Low 43.55B
Revenue High 48.32B
ende